Contact us

Our latest news

Back to news >

Continued Growth for Seda’s PK Modelling Capabilities

Seda’s modellers are multiplying!

Our PK modelling team has increased by three with the welcome addition of Stephen Checkley, Jingrao Fei, and Emily Fell, in a move to both enhance capacity and extend our modelling service offering, to meet growing demand from our clients.

We provide:

  • Physiologically based pharmacokinetics (PBPK) and allometric scaling
  • Absorption Modelling
  • Preclinical Pharmacokinetics/Pharmacodynamics (PKPD)
  • Clinical/Population PKPD
  • Translational PKPD and Non Compartmental analysis (NCA)

These go hand in hand with our laboratory and consultancy services, allowing us to support our clients all the way from discovery to market with our integrated approach to pharmaceutical development and clinical pharmacology. Please head to the  pharmacokinetic modelling expertise page on our website for more details.

About the scientists:

Stephen Checkley

Seda Associate Principal Scientist Stephen Checkley

Stephen has experience in both experimental and computational fields, building complex gene circuitry in microorganisms alongside mechanistic modelling of biological systems. Stephen has applied his experience in providing quantitative systems pharmacology (QSP) consultancy for the pharmaceutical industry as well as supporting life sciences researchers with data analysis and high-performance computing pipelines.

At Seda, Stephen will be working in the modelling team to deliver consultancy projects supporting clinical and drug development projects. Stephen will integrate his QSP experience into the range of PKPD skills within the team and work on expanding the scientific computing infrastructure with high performance computing and cloud services to increase the capacity and speed of Seda’s modelling workflows.

Jingrao Fei

Jingrao Fei

Jingrao has a BSc in Pharmaceutical Science and MSc in Model-based Drug Development from the University of Manchester. At Seda, Jingrao will be supporting translational PBPK modelling for various species or populations and assist with dose selection in early clinical stage settings.

Emily Fell

Seda Modeller Emily Fell

Emily has a First Class BEng (Hons) from the University of Birmingham studying Mechanical Engineering with a final year focus on biomedical engineering. Using her academic background and her interest in the life science industry, Emily will be working with the modelling team within Seda to support our clients on their drug development journey.

Please join us in welcoming our three new modellers to the Seda team.